Long‐Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

ABSTRACTVitamin D plays a major role in bone health and probably also in multiple extraskeletal acute and chronic diseases. Although supplementation with calcifediol, a vitamin D metabolite, has demonstrated efficacy and safety in short‐term clinical trials, its effects after long‐term monthly administration have been studied less extensively. This report describes the results of a 1‐year, phase III‐IV, double‐blind, randomized, controlled, parallel, multicenter superiority clinical trial to assess the efficacy and safety of monthly calcifediol 0.266 mg versus cholecalciferol 25,000 IU (0.625 mg) in postmenopausal women with vitamin D deficiency (25(OH)D < 20 ng/mL). A total of 303 women were randomized and 298 evaluated. Patients were randomized 1:1:1 to calcifediol 0.266 mg/month for 12 months (Group A1), calcifediol 0.266 mg/month for 4 months followed by placebo for 8 months (Group A2), and cholecalciferol 25,000 IU/month (0.625 mg/month) for 12 months (Group B). By month 4, stable 25(OH)D levels were documented with both calcifediol and cholecalciferol (intention‐to‐treat population): 26.8 ± 8.5 ng/mL (Group A1) and 23.1 ± 5.4 ng/mL (Group B). By month 12, 25(OH)D levels were 23.9 ± 8.0 ng/mL (Group A1) and 22.4 ± 5.5 ng/mL (Group B). When calcifediol treatment was withdrawn in Group A2, 25(OH)D levels decreased to baseline levels (28.5 ± 8.7 ng/mL at month 4 versus 14.4 ± 6.0 ng/mL at month 12). No relevant treatment‐related safety issues were reported in any of the groups. The results confirm that long‐term treatment with monthly calcifediol in vitamin D‐deficient patients is effective and safe. The withdrawal of treatment leads to a pronounced decrease of 25(OH)D levels. Calcifediol presented a faster onset of action compared to monthly cholecalciferol. Long‐term treatment produces stable and sustained 25(OH)D concentrations with no associated safety concerns. © 2023 Faes Farma SA. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

Autores INICO

Javier del Pino Montes

Otros Autores

Antonio Dueñas Laita, Bernat Galarraga, Carlos Gómez Alonso, Esteban Jódar, Fernando Cereto Castro, Gonzalo Hernández Herrero, Jesús González Macías, José Luis Neyro, José Luis Pérez Castrillón, José Manuel Olmos Martínez, José Manuel Quesada Gómez, Laura Gallego López, Maria Luisa Brandi, María Rosa Alhambra Expósito, Nieves Fernández Hernando, Roger Bouillon, Sandra P. Chinchilla


Pérez-Castrillón, J. L., Dueñas-Laita, A., Gómez-Alonso, C., Jódar, E., del Pino-Montes, J., Brandi, M. L., Cereto Castro, F., Quesada-Gómez, J. M., Gallego López, L., Olmos Martínez, J. M., Alhambra Expósito, M. R., Galarraga, B., González-Macías, J., Neyro, J. L., Bouillon, R., Hernández-Herrero, G., Fernández-Hernando, N., & Chinchilla, S. P. (2023). Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial. Journal of Bone and Mineral Research, 38(4), 471-479. https://doi.org/10.1002/JBMR.4776

Fecha publicación (año)